114 related articles for article (PubMed ID: 37741474)
21. Moderate Exercise in Spontaneously Hypertensive Rats Is Unable to Activate the Expression of Genes Linked to Mitochondrial Dynamics and Biogenesis in Cardiomyocytes.
Quiroga C; Mancilla G; Oyarzun I; Tapia A; Caballero M; Gabrielli LA; Valladares-Ide D; Del Campo A; Castro PF; Verdejo HE
Front Endocrinol (Lausanne); 2020; 11():546. PubMed ID: 32973679
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
23. Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats.
Jankowski M; Wang D; Danalache B; Gangal M; Gutkowska J
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H265-74. PubMed ID: 20671291
[TBL] [Abstract][Full Text] [Related]
24. Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats.
Wang H; Zhang X; Yu P; Zhou Q; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Che L; Xu J; Bei Y; Li X
Int J Med Sci; 2017; 14(5):506-514. PubMed ID: 28539827
[TBL] [Abstract][Full Text] [Related]
25. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat.
Xu X; Ding F; Pang J; Gao X; Xu RK; Hao W; Cao JM; Chen C
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(6):H703-11. PubMed ID: 22842067
[TBL] [Abstract][Full Text] [Related]
26. Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase.
Liu W; Chen J; Xu T; Tian W; Li Y; Zhang Z; Li W
Am J Hypertens; 2012 Feb; 25(2):250-60. PubMed ID: 22089109
[TBL] [Abstract][Full Text] [Related]
27. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
28. Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats.
Ayme-Dietrich E; Marzak H; Lawson R; Mokni W; Wendling O; Combe R; Becker J; El Fertak L; Champy MF; Matz R; Andriantsitohaina R; Doly S; Boutourlinsky K; Maroteaux L; Monassier L
J Hypertens; 2015 Nov; 33(11):2310-21. PubMed ID: 26259125
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of nuclear factor erythroid 2-related factor 2 signaling and activation of fibrogenic pathways in hearts of high fat diet-fed rats.
Elrashidy RA
Mol Biol Rep; 2020 Apr; 47(4):2821-2834. PubMed ID: 32239469
[TBL] [Abstract][Full Text] [Related]
30. Small Molecule Compound Nerolidol attenuates Hypertension induced hypertrophy in spontaneously hypertensive rats through modulation of Mel-18-IGF-IIR signalling.
Lin YM; Badrealam KF; Kuo CH; Daddam J; Asokan Shibu M; Lin KH; Ho TJ; Viswanadha VP; Kuo WW; Huang CY
Phytomedicine; 2021 Apr; 84():153450. PubMed ID: 33611212
[TBL] [Abstract][Full Text] [Related]
31. Oleuropein improves mitochondrial function to attenuate oxidative stress by activating the Nrf2 pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats.
Sun W; Wang X; Hou C; Yang L; Li H; Guo J; Huo C; Wang M; Miao Y; Liu J; Kang Y
Neuropharmacology; 2017 Feb; 113(Pt A):556-566. PubMed ID: 27847271
[TBL] [Abstract][Full Text] [Related]
32. Qingxuan Jiangya Decoction () Prevents Blood Pressure Elevation and Ameliorates Vascular Structural Remodeling via Modulating TGF-β 1/Smad Pathway in Spontaneously Hypertensive Rats.
He F; Chu JF; Chen HW; Lin W; Lin S; Chen YQ; Peng J; Chen KJ
Chin J Integr Med; 2020 Mar; 26(3):180-187. PubMed ID: 31883057
[TBL] [Abstract][Full Text] [Related]
33. Myocardial myostatin in spontaneously hypertensive rats with heart failure.
Damatto RL; Lima AR; Martinez PF; Cezar MD; Okoshi K; Okoshi MP
Int J Cardiol; 2016 Jul; 215():384-7. PubMed ID: 27128567
[TBL] [Abstract][Full Text] [Related]
34. The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.
Iemitsu M; Shimojo N; Maeda S; Irukayama-Tomobe Y; Sakai S; Ohkubo T; Tanaka Y; Miyauchi T
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H136-44. PubMed ID: 18456726
[TBL] [Abstract][Full Text] [Related]
35. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
36. Astaxanthin promotes M2 macrophages and attenuates cardiac remodeling after myocardial infarction by suppression inflammation in rats.
Pan X; Zhang K; Shen C; Wang X; Wang L; Huang YY
Chin Med J (Engl); 2020 Aug; 133(15):1786-1797. PubMed ID: 32701588
[TBL] [Abstract][Full Text] [Related]
37. Zinc deficiency increases lung inflammation and fibrosis in obese mice by promoting oxidative stress.
Luan R; Luo M; Ding D; Su X; Yang J
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130518. PubMed ID: 37951369
[TBL] [Abstract][Full Text] [Related]
38. The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.
Lee HC; Shiou YL; Jhuo SJ; Chang CY; Liu PL; Jhuang WJ; Dai ZK; Chen WY; Chen YF; Lee AS
Cardiovasc Diabetol; 2019 Apr; 18(1):45. PubMed ID: 30935417
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil elastase inhibitor suppresses oxidative stress in obese asthmatic rats by activating Keap1/Nrf2 signaling pathway.
Zheng JQ; Zhang GR; Li J; Bi HW
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):361-369. PubMed ID: 30657578
[TBL] [Abstract][Full Text] [Related]
40. Butein Inhibits Oxidative Stress Injury in Rats with Chronic Heart Failure via ERK/Nrf2 Signaling.
Liu P; Pan Q
Cardiovasc Ther; 2022; 2022():8684014. PubMed ID: 35069800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
